Public notice & comment
Deadline: 6 May 2024, 16:00 CET
Relating to call for experts issued on 20 November 2023
Following a public call for experts and rigorous selection process, the World Health Organization announces the proposed updated membership of the WHO Strategic Technical Advisory Group on Antimicrobial resistance (STAG-AMR). As per WHO processes for transparency in provision of technical/normative advice to WHO, this public notice is followed by a two-week comment period. Appointments to the STAG-AMR are subject to this comment period and relevant WHO practices and procedures.
Function of the STAG-AMR:
The STAG-AMR was reconstituted in November 2020 and provides independent strategic and technical advice to WHO on global policies and strategies to address AMR within the context of human health, while considering relevant World Health Assembly (WHA) resolutions and decisions.
In its capacity as an advisory body to WHO, the STAG-AMR has the following functions:
- To review progress in the implementation of WHO’s priority activities to tackle AMR in countries consistent with WHO’s mandate, relevant WHA resolutions and decisions, and the strategic objectives of the Global Action Plan on AMR (2015), and make recommendations;
- To provide an independent evaluation of the major strategic, scientific and technical challenges and opportunities to be addressed by WHO in order to enhance progress in addressing AMR in the context of human health;
- To review the adequacy of WHO’s response to emerging national and global public health risks with regard to AMR and make recommendations;
- To review and make recommendations on the status of linkages between AMR and other health interventions, and other relevant sectors;
- To review and make recommendations on WHO’s engagement in partnerships to enhance the achievement of global AMR goals.
Following confirmation of its updated membership, the next STAG-AMR meeting is planned for June 2024.
Proposed STAG-AMR members
20 members were appointed to the reconstituted STAG-AMR in November 2020, with a three-year term. An open call was launched in November 2023 to update the STAG-AMR membership. 26 proposed STAG-AMR members were identified based on evaluation of applications against criteria specified in the STAG-AMR Terms of Reference, with consideration also given to attaining an adequate distribution of technical expertise, geographical representation and gender balance.
The 26 proposed STAG-AMR members represent a diverse spectrum of expertise ranging from AMR governance, global health financing, surveillance, prevention, and control, to R&D innovations and community engagement. The members are to serve in their personal capacities.
Public notice and comment
Pursuant to WHO’s rules and practices, and in order to enhance WHO’s management of conflicts of interest, as well as strengthen public trust and transparency in connection with WHO advisory groups involving the provision of technical advice, the names and brief biographies of the individuals selected for STAG-AMR Membership are now disclosed for public notice and comment.
Should you wish to comment on the individuals, please send your comments to STAG-AMR@who.int with subject, “Public comments on STAG-AMR members,” by 6 May 2024, 16:00 CET.
WHO will treat the comments received through this public notice and comment process confidentially. Comments and perceptions brought to the attention of WHO through this process are an integral component of WHO’s conflict of interest assessment policy and will, subject to WHO’s rules, practices, and policies, be carefully reviewed by WHO. WHO reserves the right to discuss information received through this process with the relevant expert and otherwise within the Organization as appropriate, with no attribution to the provider of the information. WHO, may, in its sole discretion, take appropriate action in accordance with its rules, practices, and policies, based on any information received.
Disclaimer:
In order to enhance its management of Conflicts of Interest as well as strengthen public trust and transparency in connection with WHO meetings involving the provision of technical/normative advice, the names and brief biographies of individuals (“Published Information” ) being considered for participation in such meetings are disclosed for public notice and comment.
The Published Information is provided by the experts themselves and is the sole responsibility of the individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the Published Information provided. Furthermore, in no event will WHO be responsible or liable for damages in relation to the use of, and reliance upon, the Published Information.
The comments received by WHO through the public notice and comment process are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Comments and perceptions brought to the knowledge of WHO through this process are an integral component of WHO’s conflict of interest assessment policy and are carefully reviewed. WHO reserves the right to discuss information received through this process with the relevant expert with no attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies.
The participation of an expert in a WHO meeting does not imply that they are endorsed or recommended by the World Health Organization nor does it create a binding relationship between the expert and WHO.
The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate mitigation measures taken by WHO relating to the management of conflicts of interests, will be reported publically in accordance with WHO practice.